1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Tarceva Forecast

Tarceva Forecast

  • May 2014
  • -
  • BCC Research
  • -
  • 36 pages

Summary

Table of Contents

The BCC Research Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters.

The introductory sample of the Tarceva Forecast Model was already sent in the update earlier today. I have attached it again for your reference.

The model features:

- Market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)
- Segmentation of volume and value for the following regions: U.S., Japan, Europe, Latin America, China, Asia, Middle East
- Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence

Click here to view a data sheet of the Tarceva Forecast Model.

Use the BCC Research Tarceva Forecast to:

- Examine forecasted market demand for Tarceva: competitor assessment; market opportunity assessment
- Identify new business and investment opportunities for products in the lung cancer segment
- Validate other Tarceva market-demand data to which you have access

Tarceva Forecast, a strategic investment product designed to provide critical market data for the pharmaceutical cancer drug Tarceva.
 
Tarveca (Astellas Pharma) is a once-daily, oral, non-chemotherapy prescription drug for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). Some clinical studies have shown superior patient outcomes from use of Tarceva as a second-line treatment for NSCLC. Starting in 2020, Tarceva begins to lose patent protection in numerous countries.
 
Through Tarceva Forecast, BCC Research provides high-quality intelligence for strategic decision-making regarding future participation in this large and important market. Market players can use Tarceva Forecast to examine forecasted market demand for Tarceva, identify new business and investment opportunities for related products and services, and validate other Tarceva market-demand data.
 
Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters, featuring market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume and value. Data transparency and sources are disclosed for patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence, as well as for population estimates at the country level and product pricing and currency valuation forecasts. Information is segmented by the following regions:  United States, Japan, Europe, Latin America, China, Asia, Middle East.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected ...

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Analyze the global prostate cancer market, with important statistics and analysis on existing drugs, and diagnostic technologies. - Receive information on regulatory environment, ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics - Forecast

  • April 2017
    10 pages
  • Cancer  

  • Europe  

    United Kingdom  

    United States  

View report >

Cancer Statistics in the US

  • April 2017
    24 pages
  • Cancer  

    Healthcare Fina...  

  • United States  

View report >

Leukemia Statistics

  • April 2017
    16 pages
  • Leukemia  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.